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In this  study  we  investigated  whether  oral  uptake  of  a heat  inactivated  M.  bovis  wildlife  vaccine  by
domestic  cattle  induced  systemic  immune  responses  that  compromised  the  use of tuberculin  or deﬁned
antigens  in  diagnostic  tests  for bovine  TB.  Positive  skin  test  and blood-based  IFN-  release  assay  (IGRA)
results  were  observed  in all calves  vaccinated  via  the parenteral  route  (i.e.  intramuscular).  In contrast,
no  positive  responses  to tuberculin  or  deﬁned  antigens  were  observed  in  either  the  skin test  or  IGRA testovine TB
iagnostic tests
eat killed M.  bovis
accination
when  performed  in calves  vaccinated  via  the  oral  route.  In conclusion,  our  results  suggest  that  the heat
inactivated  M.  bovis  vaccine  could  be used  to vaccinate  wildlife  in  a baited  form  in conjunction  with  the
following  in  cattle:  (i)  continuation  of  existing  tuberculin  skin  testing  or novel  skin  test formats  based  on
deﬁned  antigens;  and  (ii)  the  use  of  IGRA  tests  utilizing  tuberculin  or deﬁned  antigens.
Crown  Copyright  © 2016  Published  by  Elsevier  B.V.  This  is  an  open  access  article  under  the  Open
Government  License  (OGL)  (http://www.nationalarchives.gov.uk/doc/open-government-licence/. Introduction
Several wildlife reservoirs have been implicated in the main-
enance of cattle TB, including the Brushtail possum (Trichosurus
ulpecula) in New Zealand (Pfeiffer et al., 1995), white-tailed deer
Odocoileus virginianus) in the USA (Schmitt et al., 1997), African
uffalo (Syncerus caffer) in South Africa (De Vos et al., 2001),
urasian badgers (Meles meles) in the Republic of Ireland and United
ingdom (Cheeseman et al., 1989), and Eurasian wild boar (Sus
crofa) in Spain (Vicente et al., 2007). As such, vaccination of wildlife
pecies to reduce M.  bovis infection prevalence has been proposed
s a tool to support TB control programmes. Oral delivery of Baccille
almette-Guerin (BCG), a live avirulent strain of M. bovis, resulted
n reduced incidence and/or severity of tuberculous lesions in wild
oar (Ballesteros et al., 2009), ferrets (Qureshi et al., 1999), Brush-
ail possums (Tompkins et al., 2013), Eurasian badgers (Corner et al.,
010) and White-tailed deer (Nol et al., 2008) following experimen-
al challenge with M.  bovis. Importantly, this protection was  also
vident when BCG was delivered in ‘bait’ form (Ballesteros et al.,
009; Garrido et al., 2011; Nol et al., 2008). However, it has been
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proposed that using inactivated vaccines would have an advantage
for TB control in wildlife, in that they would be environmentally
safer and more stable under ﬁeld conditions compared to live BCG
(Garrido et al., 2011). One such vaccine, based on heat inactivated M.
bovis strain 1403 delivered in bait form, provided protection from
M. bovis challenge in wild boar (Garrido et al., 2011). The concern,
however, is that bystander consumption of these baits by cattle may
sensitise these animals to diagnostic surveillance tests for bovine
TB. To test this hypothesis, we investigated whether oral uptake
of the heat inactivated M.  bovis wildlife vaccine by domestic cattle
induced systemic immune responses that compromised the use of
either tuberculin or deﬁned antigens in diagnostic assays for bovine
TB, e.g. skin test or blood-based IFN- release assays (IGRA).
2. Material and methods
2.1. Cattle
Calves (aged 5–7 months) were obtained from TB-free herds
located in non-endemic areas of the UK. All animals were housed
at the Animal and Plant Health Agency for the duration of the study,
and procedures were conducted within the limits of a United King-
dom Home ofﬁce license under the Animal (Scientiﬁc Procedures)
Act 1986, which were approved by the APHA Animal Welfare and
Ethical Review Body (AWERB) committee.
cle under the Open Government License (OGL) (http://www.nationalarchives.
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Fig. 1. Skin test responses in cattle vaccinated with heat inactivated M.  bovis. Six
calves were vaccinated either by the intramuscular (closed circles) or the oral (open
circles) route, and the skin test results are expressed as the difference in skin thick-
ness (mm)  between the pre and post skin test readings. Each circle represents an
individual animal, while the horizontal line provides the median value. The number
of  test positive animals for the SIT (PPDB), SICCT (B-A) and deﬁned antigen reagents
(APHA-1 and APHA-2) were determined as described in the material and methods6 G.J. Jones et al. / Veterinary Immunolog
.2. Vaccination
Six calves were immunised with 106–107 CFU of the heat killed
. bovis vaccine by either the oral or intramuscular route accord-
ng to the supplier’s guidelines (Neiker, Spain). The vaccine dose
as chosen as it replicated that used in previous wild boar oral bait
accine studies (Beltran-Beck et al., 2014; Garrido et al., 2011). The
ral vaccine consisted of 0.2 ml  of the inactivated M. bovis suspen-
ion and 4.8 ml  of sterile PBS, which was administered in the lateral
egion of the mouth after slightly raising the head of the calves. For
arenteral immunisation, 0.2 ml  of the inactivated M. bovis suspen-
ion was homogenised with 0.8 ml  of Montanide ISA 50 V2 (Seppic,
rance) and administered via the intramuscular route.
.3. Skin tests
Six weeks post vaccination, all animals received intradermal
njections (0.1 ml  volume) in the neck with the following test
eagents: (i) avian tuberculin (PPDA; 2500 IU [Prionics]); (ii) bovine
uberculin (PPDB; 3000 IU [Prionics]); (iii) APHA-1 (protein cocktail
onsisting of ESAT-6, CFP-10 and Rv3615c); and (iv) APHA-2 (pro-
ein cocktail consisting of ESAT-6, CFP-10, Rv3615c and Rv3020c).
ll recombinant proteins were obtained from Lionex (Germany)
nd used at a concentration of 10 g of individual protein per injec-
ion. Skin induration was measured at the injection sites prior to
nd 72 h after the skin test, and the results expressed as the dif-
erence in skin thickness between the two readings ( mm).  The
riteria for a positive skin test with the different reagents were
s follows: (i) SIT responses were considered positive if  skin
hickness for PPDB is ≥4 mm;  (ii) SICCT responses were considered
ositive if  skin thickness for PPDB – PPDA is >4 mm (‘stan-
ard’ OIE and UK test interpretation); and (iii) APHA-1 and APHA-2
esponses were considered positive if  skin thickness is ≥2 mm.
.4. Whole blood IGRA
Whole blood IGRA was performed on samples collected at
re and post vaccination time points. Whole blood samples were
timulated for 24 h with bovine and avian tuberculin (300 IU/ml
nd 250 IU/ml respectively) or with peptide cocktails contain-
ng the following deﬁned antigens: (i) E/C (ESAT-6 and CFP-10
APHA]) (Vordermeier et al., 2001); (ii) Rv3615c (APHA) (Sidders
t al., 2008); (iii) PC-EC (ESAT-6 and CFP-10 [Prionics]); and (iv)
C-HP (ESAT-6, CFP-10 and 4 additional mycobacterial gene prod-
cts [Prionics]). All peptides were used at a concentration of
 g/peptide/ml. Samples were also stimulated with RPMI 1640
lone or 10 g/ml pokeweed mitogen (Sigma-Aldrich) to act as neg-
tive and positive controls respectively. IFN- levels in the plasma
upernatant were quantiﬁed using the Bovigam ELISA kit (Prionics).
esponses to the tuberculin reagents were considered positive if
he O.D. for PPDB stimulated cultures minus the O.D. for PPDA stim-
lated cultures was >0.1, whilst responses to the peptide cocktails
ere considered positive if the O.D. for peptide stimulated cultures
inus the O.D. for unstimulated cultures was >0.1.
.5. Statistical analysis
Statistical analysis was performed using GraphPad Prism 6 soft-
are (GraphPad Software Inc.). Comparison of increases in skin
hickness was performed using the Mann Whitney test, while the
roportion of animals testing positive in skin tests or IGRA were
ompared using the Fisher’s exact test.section. * p < 0.01, Mann Whitney test, ** p < 0.01, Fisher’s exact test (versus oral
vaccination).
3. Results and discussion
As shown in Fig. 1, vaccination via the intramuscular route
induced signiﬁcantly greater (p < 0.01, Mann Whitney test)
increases in skin thickness to PPDA, PPDB and B-A compared to the
oral route. Furthermore, signiﬁcant differences (p < 0.01, Fisher’s
exact test) in the proportion of animals testing positive to the tuber-
culin reagents were observed between the different groups, where
all six calves immunised via the intramuscular route showed pos-
itive skin test reactions when using the SIT or SICCT test readouts
(PPDB and B-A respectively), while no positive skin test reactions
were observed in any of the calves vaccinated via the oral route
when using these readouts. These results are similar to that recently
reported in red deer, where oral vaccination with the heat killed M.
bovis vaccine did not induce false-positive responses to the tuber-
culin skin test (Lopez et al., 2016). The deﬁned antigen skin test
reagents APHA-1 and APHA-2 have been developed as potential
alternatives to tuberculin-based test reagents, and data from APHA
has demonstrated that these deﬁned antigen reagents induced pos-
itive skin test reactions in M.  bovis-infected cattle (APHA-1 [n = 75]:
test sensitivity of 85.3% [95%CI of 75.3–92.4%]; APHA-2 [n = 26]: test
sensitivity 89.7% [95%CI of 72.7–97.8%], data not shown). In this
present study, limited skin test reactions to these reagents were
observed in animals immunised with heat killed M.  bovis. With the
exception of one animal immunised via the intramuscular route
testing positive to APHA-1, none of the calves vaccinated with heat
killed M. bovis, via either the oral or intramuscular route, tested pos-
itive to either of the deﬁned antigen skin test reagents. Whole blood
IGRA tests using tuberculin and deﬁned antigen reagents were also
performed pre- and post-vaccination. All 12 animals demonstrated
IFN- responses to the positive mitogen control (data not shown).
None of the animals vaccinated by the oral route tested positive
in the IGRA assay to the tuberculin reagents at any time point
(Table 1). Similarly, no responses were observed to the deﬁned anti-
gen peptide cocktails, with the exception of one animal that tested
positive to the PC-HP peptide cocktail at week 7 post-vaccination.
In contrast, a signiﬁcantly greater (p < 0.01, Fisher’s exact test) pro-
portion of test positive results were observed in the intramuscular
vaccinated group, where all six animals showed positive IGRA test
results to the tuberculin reagents 2 weeks post vaccination, which
persisted for the duration of the experiment. These results are con-
sistent with a study in wild boar where parenteral, but not oral,
vaccination induced PPDB-speciﬁc IFN- production (Garrido et al.,
G.J. Jones et al. / Veterinary Immunology and
Table  1
IGRA responses in cattle vaccinated with heat inactivated M. bovis.
Antigen Routea Week 0 Week 2 Week 4 Week 6 Week 7 Week 8
B-Ab i.m. 1/6 6/6** 6/6** 6/6** 6/6** 6/6**
oral 0/6 0/6 0/6 0/6 0/6 0/6
E/Cc i.m. 0/6 3/6 6/6** 6/6** 6/6** 6/6**
oral 0/6 0/6 0/6 0/6 0/6 0/6
Rv3615cc i.m. 0/6 0/6 0/6 0/6 1/6 1/6
oral 0/6 0/6 0/6 0/6 0/6 0/6
PC-ECc i.m. 0/6 1/6 5/6* 4/6 6/6** 3/6
oral 0/6 0/6 0/6 0/6 0/6 0/6
PC-HPc i.m. 0/6 2/6 6/6** 5/6* 6/6* 4/6
oral 0/6 0/6 0/6 0/6 1/6 0/6
Bold denotes where positive responses were observed.
*p  < 0.05, ** p < 0.01, Fisher’s exact test (versus oral vaccination).
a Cattle were vaccinated via the intramuscular (i.m.) or oral route.
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tb Response considered positive if O.D. PPDB – O.D. PPDA > 0.1
c Response considered positive if O.D. antigen – O.D. nil > 0.1
011). Frequent responses to the deﬁned antigen peptide cock-
ails were also observed following intramuscular immunisation
Table 1). Responses to the E/C peptide cocktail were ﬁrst seen
 weeks post vaccination, which persisted throughout the course
f the experiment in all animals. Similar results were seen with
he PC-EC and PC-HP peptide cocktails; although the frequencies
f response were lower at some time points when compared to
he E/C cocktail. In contrast, only one animal tested positive to the
v3615c peptide cocktail. It is interesting to note that this response
rst occurred at week 7 post vaccination, which was one week after
he skin tests were performed. We  also observed an increase in the
roportion of animals in the intramuscular vaccination group test-
ng positive to the PC-EC and PH-HP reagents at week 7 compared
o week 6, although this did not achieve statistical signiﬁcance (at
he p < 0.05 level, Fisher’s exact test) and did not persist to week 8.
hese results are consistent with the speculation that the skin tests
nduced a transient boost in IGRA responses to the deﬁned antigens,
ut further experiments with greater numbers of animals would be
equired to conﬁrm this.
In conclusion, our results support a recommendation that the
eat inactivated M.  bovis vaccine could be used to vaccinate wildlife
n a baited form in conjunction with the following in cattle: (i)
ontinuation of existing tuberculin skin testing or novel skin test
ormats based on deﬁned antigens; and (ii) the use of IGRA tests
tilizing tuberculin or deﬁned antigens. However, these recom-
endations come with some caveats. Firstly, we applied only a
ingle oral dose of this vaccine to cattle. The effect of oral vaccine
ose on skin test reactivity has been investigated in cattle vacci-
ated with BCG (Buddle et al., 2005; Wedlock et al., 2011), which
howed a trend for increased proportions of animals testing posi-
ive in tuberculin skin tests following vaccination with higher doses
f vaccine. Secondly, we chose to assess skin test responses at week
 post vaccination as we deemed this sufﬁcient time for vaccination
ith heat inactivated M.  bovis to induce a systemic cell mediated
mmune response (as supported by the data in Table 1 and Fig. 1
or intramuscular vaccinated animals). It is possible that induction
f systemic immunity following oral vaccination with heat inac-
ivated M.  bovis may  be delayed, as previously observed in mice
Aldwell et al., 2003b), possums (Aldwell et al., 2003a) and cat-
le (Buddle et al., 2005) following oral BCG vaccination, although
hese studies employed a live vaccine (i.e. BCG) and their rele-
ance to oral vaccination with heat killed M.  bovis is uncertain.
hus, further studies vaccinating cattle with multiple oral doses
f the heat inactivated M.  bovis vaccine and analysing IGRA and
kin test reactivity at extended time points are required to con-
rm the ﬁndings presented herein. Although beyond the remit of
his study, we acknowledge that vaccine-challenge studies in cat-
le will be required to test the efﬁcacy of this vaccine when given Immunopathology 182 (2016) 85–88 87
by the oral route, should its application to cattle be considered.
Lastly, due to its interference in diagnostic tests for bovine TB, we
do not recommend using this vaccine in cattle via the parenteral
route in TB control programmes combining vaccination with test
and slaughter.
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